The Inhibitory Effects of Alpha 1 Antitrypsin on Endosomal TLR Signaling Pathways

The Inhibitory Effects of Alpha 1 Antitrypsin on Endosomal TLR Signaling Pathways

Endosomal toll-like receptors (TLRs) TLR7, TLR8, and TLR9 play an important role in systemic lupus erythematosus (SLE) pathogenesis. The proteolytic processing of these receptors in the endolysosome is required for signaling in response to DNA and single-stranded RNA, respectively. Targeting this pr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ahmed S. Elshikha, Georges Abboud, Rigena Avdiaj, Laurence Morel, Sihong Song
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Biomolecules
Subjects:	systemic lupus erythematosus (SLE) inflammation toll-like receptors (TLRs) human alpha-1 antitrypsin (hAAT)
Online Access:	https://www.mdpi.com/2218-273X/15/1/43
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Role of alpha-1 antitrypsin in Bruch’s membrane integrity
by: Shun-Yun Cheng, et al.
Published: (2025-04-01)

Accurate Indentification of Pathogenic Mutations Conferring α1-Antitrypsin Deficiency by a Novel Multiplexed Molecular AssayTake-home Points
by: Emily K. DeCurtis, BSc, et al.
Published: (2025-03-01)

“Alpha-1, are you in? (C)harlie (O)scar (P)appa (D)elta, over!”
by: G. L. Muntingh
Published: (2016-01-01)

Alpha-1 antitrypsin deficiency-associated panniculitis: a case report
by: Špela But, et al.
Published: (2025-06-01)

Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016-12-01)

Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy
by: Atharv V. Oak, MEng, et al.
Published: (2025-02-01)

Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency
by: Paulo Henrique Ramos Feitosa, et al.
Published: (2024-12-01)

Alpha-1 antitrypsin in COVID-19 patients: a dual-center screening study in Malaysia
by: Norsyuhadah Musa, et al.
Published: (2025-07-01)

Administration of Purified Alpha-1 Antitrypsin in Salt-Loaded Hypertensive 129Sv Mice Attenuates the Expression of Inflammatory Associated Proteins in the Kidney
by: Van-Anh L. Nguyen, et al.
Published: (2025-06-01)

Alpha-1 Antitrypsin Deficiency and Bronchial Asthma: Current Challenges
by: José Luis Lopez-Campos, et al.
Published: (2025-06-01)

Patient-centered assessment of treatment for alpha-1 antitrypsin deficiency: literature review to identify concepts and measures for people with alpha1-antitrypsin deficiency
by: Ekin Seçinti, et al.
Published: (2025-02-01)

Analysis of Association of Asp299Gln (rs 4986790) and Thr399Ile (rs 4986791) Polymorphisms of the <i>TLR4</i> Gene with Risk of Developing Lung Sarcoidosis (Using the Example of Residents of Karelia)
by: I. E. Malysheva, et al.
Published: (2022-10-01)

Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye
by: Dilek Karadoğan, et al.
Published: (2024-12-01)

THE DIAGNOSTIC AND CLINICAL VALUE OF DETERMINATION OF α1-ANTITRYPSIN PHENOTYPE IN SYSTEMIC VASCULITIDES
by: M. Yu. Pervakova, et al.
Published: (2017-04-01)

Characterization of the Mmalton carrier’s cohort within the EARCO (European Alpha- 1 Antitrypsin Research Collaboration) registry
by: Beatriz D. Ferraz, et al.
Published: (2025-04-01)

Alpha-1 antitrypsin reduces inflammation and vasculopathy in mice with oxygen-induced retinopathy
by: Varaporn Suphapimol, et al.
Published: (2025-02-01)

Prevalence of genetic mutations in Alpha-1 antitrypsin in patients with difficult-to-treat asthma in Colombia
by: Abraham Alí-Munive, et al.
Published: (2025-08-01)

Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes
by: Ilaria Ferrarotti, et al.
Published: (2025-12-01)

Alpha-1 Antitrypsin as a Regulatory Protease Inhibitor Modulating Inflammation and Shaping the Tumor Microenvironment in Cancer
by: Siyu Xiang, et al.
Published: (2025-01-01)

Is It Time Alpha-1 Antitrypsin Deficiency Had a Specific Patient Reported Outcome Measure? A Review
by: De Soyza J, et al.
Published: (2025-01-01)

The role of microbiota and toll-like receptors in polycystic ovary syndrome: regulatory mechanisms of androgen metabolism
by: Xueming Huang, et al.
Published: (2025-06-01)

Immunoinformatics-driven design of a multi-epitope vaccine targeting neonatal rotavirus with focus on outer capsid proteins VP4 and VP7 and non structural proteins NSP2 and NSP5
by: Arijit Das Sharma, et al.
Published: (2025-04-01)

High glucose heightens vulnerability to Leishmania braziliensis infection in human macrophages by hampering the production of reactive oxygen species through TLR2 and TLR4
by: Ícaro Bonyek-Silva, et al.
Published: (2025-12-01)

The Role of Inflammatory Pathways in the Development of Rosacea
by: Kamila Sieradocha, et al.
Published: (2024-11-01)

Alpha-1 Antitrypsin Deficiency-Associated Clinical Manifestations and Healthcare Resource Use in the United States
by: Ernesto Mayen Herrera, et al.
Published: (2021-05-01)

Gastroparesis and Systemic Lupus Erythematosus: A Propensity Score‐Matched Study of US National Database Analysis
by: Noppachai Siranart, et al.
Published: (2025-07-01)

Two Sisters were Diagnosed with Childhood Systemic Lupus Erythematous
by: ALAA NASRAWI, et al.
Published: (2022-12-01)

Fucoidan as a therapeutic agent for ulcerative colitis: mechanisms of action and modulation of the gut microbiota
by: Yating Zhang
Published: (2025-07-01)

a1-antitrypsin, a new biomarker of polycystic ovary syndrome by changing its expression and rhythm
by: Na Li, et al.
Published: (2025-05-01)

Development of a small molecule that corrects misfolding and increases secretion of Z α1‐antitrypsin
by: David A Lomas, et al.
Published: (2021-01-01)

Enhancement of plasma kallikrein specificity of antitrypsin variants identified by phage display and partial reversion
by: Sangavi Sivananthan, et al.
Published: (2025-03-01)

Molecular characterization and immune role of TLR7 in Labeo rohita
by: Saswati Pani, et al.
Published: (2025-04-01)

Contents of plasmin, α1-antitrypsin and α2-macroglobulin in blood of patients with cerebral infarction and discircular encephalopathy before the treatment
by: N. A. Kuznetsova, et al.
Published: (2004-09-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

Clinical features of patients with systemic lupus erythematosus (SLE) attending the SLE outpatient clinic at Universitas Hospital in Bloemfontein, South Africa
by: Robyn Carey, et al.
Published: (2008-02-01)

Impact of Sex on Infection Risk in Patients with Systemic Lupus Erythematosus
by: R. Borrelli, et al.
Published: (2025-01-01)

Imiquimod, a Promising Broad-Spectrum Antiviral, Prevents SARS-CoV-2 and Canine Coronavirus Multiplication Through the MAPK/ERK Signaling Pathway
by: Josefina Vicente, et al.
Published: (2025-05-01)

Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?
by: Senthil Kumaran Satyanarayanan, et al.
Published: (2025-03-01)

Immune and Inflammatory Pathways in Non-Alcoholic Steatohepatitis (NASH). An update
by: Sorina Cezara Coste, et al.
Published: (2019-05-01)

Genome-wide identification of the AAT gene family in quinoa and analysis of its expression pattern under abiotic stresses
by: Hanxue Li, et al.
Published: (2025-03-01)